- Home
- BDTX vs STG Comparison
BDTX vs STG Comparison
Compare BDTX & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- STG
- Stock Information
- Founded
- BDTX 2014
- STG 2003
- Country
- BDTX United States
- STG China
- Employees
- BDTX N/A
- STG N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- STG Other Consumer Services
- Sector
- BDTX Health Care
- STG Real Estate
- Exchange
- BDTX Nasdaq
- STG Nasdaq
- Market Cap
- BDTX 96.9M
- STG N/A
- IPO Year
- BDTX 2020
- STG 2018
- Fundamental
- Price
- BDTX $1.61
- STG $5.45
- Analyst Decision
- BDTX Strong Buy
- STG
- Analyst Count
- BDTX 5
- STG 0
- Target Price
- BDTX $15.60
- STG N/A
- AVG Volume (30 Days)
- BDTX 8.2M
- STG 4.5K
- Earning Date
- BDTX 03-06-2025
- STG 03-21-2025
- Dividend Yield
- BDTX N/A
- STG N/A
- EPS Growth
- BDTX N/A
- STG N/A
- EPS
- BDTX N/A
- STG 3.43
- Revenue
- BDTX N/A
- STG $272,664,301.00
- Revenue This Year
- BDTX N/A
- STG N/A
- Revenue Next Year
- BDTX N/A
- STG N/A
- P/E Ratio
- BDTX N/A
- STG $1.65
- Revenue Growth
- BDTX N/A
- STG N/A
- 52 Week Low
- BDTX $1.55
- STG $4.25
- 52 Week High
- BDTX $7.66
- STG $11.06
- Technical
- Relative Strength Index (RSI)
- BDTX 38.60
- STG 42.75
- Support Level
- BDTX $1.55
- STG $5.40
- Resistance Level
- BDTX $1.84
- STG $5.57
- Average True Range (ATR)
- BDTX 0.23
- STG 0.29
- MACD
- BDTX 0.01
- STG 0.01
- Stochastic Oscillator
- BDTX 5.26
- STG 63.78
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.